Literature DB >> 10708961

TGF-beta in blood: a complex problem.

D J Grainger1, D E Mosedale, J C Metcalfe.   

Abstract

The cytokine transforming growth factor-beta (TGF-beta) was initially purified from human platelets, a rich source of this protein. In addition to platelets, TGF-beta1 is also found in other blood fractions, including plasma and the circulating leukocytes. However, more than 15 years after the initial isolation of TGF-beta1, there remains no consensus on how much TGF-beta1 is present in normal human plasma. Here we review the difficulties associated with measuring TGF-beta concentrations in complex biological fluids, and discuss the current state of knowledge on the distribution of TGF-beta isoforms in various blood fractions as well as the nature of the TGF-beta-containing protein complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708961     DOI: 10.1016/s1359-6101(99)00037-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  58 in total

1.  Exercise-induced changes in circulating levels of transforming growth factor-beta-1 in humans: methodological considerations.

Authors:  Katja Heinemeier; Henning Langberg; Michael Kjaer
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

2.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 3.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

4.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

Review 5.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

6.  New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.

Authors:  Donna Mancini; Juan Monteagudo; Mayte Suárez-Fariñas; Jeffrey Bander; Rohan Varshney; Juana Gonzalez; Barry S Coller; Jasimuddin Ahamed
Journal:  Transl Res       Date:  2017-11-05       Impact factor: 7.012

7.  Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies.

Authors:  E C Ebert; A Panja; K M Das; R Praveen; X Geng; C Rezac; M Bajpai
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs.

Authors:  Stephan Neumann; Franz-Josef Kaup; Baerbel Beardi
Journal:  Can J Vet Res       Date:  2008-10       Impact factor: 1.310

9.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04

10.  Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis.

Authors:  S Wilson; F M Jones; J K Mwatha; G Kimani; M Booth; H C Kariuki; B J Vennervald; J H Ouma; E Muchiri; D W Dunne
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.